
Direct-to-consumer pharmaceutical advertising (DTCPA) has grown rapidly during the past several decades and is now the most prominent type of health communication that the public encounters.1–3 The FDA regulates DTCPA, but critics say that the rules are too relaxed and inadequately enforced.4–6















